TWD 22.05
(-6.37%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -120.57 Million TWD | 32.31% |
2022 | -178.11 Million TWD | 23.11% |
2021 | -231.65 Million TWD | 35.04% |
2020 | -356.59 Million TWD | 30.33% |
2019 | -511.84 Million TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -125.82 Million TWD | -4.36% |
2024 Q2 | -111.14 Million TWD | 11.67% |
2023 Q3 | -166.33 Million TWD | 6.53% |
2023 FY | -120.57 Million TWD | 32.31% |
2023 Q1 | -174.56 Million TWD | 0.0% |
2023 Q2 | -177.94 Million TWD | -1.94% |
2023 Q4 | -120.57 Million TWD | 27.51% |
2022 Q4 | - TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 54.359% |
Level Biotechnology Inc. | -453.9 Million TWD | 73.437% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | 38.609% |
TaiMed Biologics Inc. | 499.84 Million TWD | 124.121% |
GlycoNex Incorporation | -148.56 Million TWD | 18.845% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | 399.434% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 187.373% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 54.083% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 494.303% |
Visgeneer Inc. | 31.28 Million TWD | 485.405% |
Mycenax Biotech Inc. | 207 Million TWD | 158.244% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 82.285% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 10.191% |
Neith Corporation | -150.31 Million TWD | 19.786% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 119.399% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -109.112% |
Enimmune corporation | -314.15 Million TWD | 61.621% |
TaiRx, Inc. | -147.86 Million TWD | 18.462% |
EirGenix Inc. | -4.58 Billion TWD | 97.372% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -42.244% |
Sunny Pharmtech Inc. | 120.87 Million TWD | 199.751% |
Lin BioScience, Inc. | -3.21 Billion TWD | 96.253% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 62.015% |
Feng Chi Biotech Corp. | -19.81 Million TWD | -508.54% |
Bio Preventive Medicine Corp. | 31.8 Million TWD | 479.044% |
Lukas Biomedical Inc. | 50.75 Million TWD | 337.553% |
RBC Bioscience Corporation | 422.18 Million TWD | 128.559% |
BiOptic Inc. | 12.59 Million TWD | 1057.513% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 87.233% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -18.805% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 27.005% |
VBI | -25.31 Million TWD | -376.26% |
CHO Pharma, Inc. | -203.79 Million TWD | 40.837% |
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -56.495% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 138.292% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -87.45% |
NaviFUS Corp. | -123.12 Million TWD | 2.078% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 262.82% |
Sinew Pharma Inc. | -160.34 Million TWD | 24.806% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 50.156% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 64.262% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 70.781% |
AP Biosciences Inc | -196.52 Million TWD | 38.65% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 117.506% |
3D Global Biotech Inc. | -11.43 Million TWD | -954.21% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 85.468% |
Intech Biopharm Corporation | 1.35 Billion TWD | 108.883% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | 70.938% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 42.404% |
TWi Biotechnology, Inc. | -143.86 Million TWD | 16.191% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 63.524% |
TCI GENE Inc. | -689.25 Million TWD | 82.507% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -1.372% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 90.791% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 688.634% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -18.357% |
PharmaEngine, Inc. | -860.8 Million TWD | 85.993% |
Savior Lifetec Corporation | -812.54 Million TWD | 85.161% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 59.806% |
OBI Pharma, Inc. | -398.22 Million TWD | 69.723% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | 67.005% |
Acepodia, Inc. | -6.02 Billion TWD | 97.997% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 96.456% |